{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T06:17:27Z","timestamp":1772691447021,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019035","name":"Hubei Province Science and Technology Program","doi-asserted-by":"publisher","award":["2020ACA019"],"award-info":[{"award-number":["2020ACA019"]}],"id":[{"id":"10.13039\/501100019035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019035","name":"Hubei Province Science and Technology Program","doi-asserted-by":"publisher","award":["2021ACA004"],"award-info":[{"award-number":["2021ACA004"]}],"id":[{"id":"10.13039\/501100019035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003633"],"award-info":[{"award-number":["82003633"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.bbrc.2022.07.050","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T22:38:12Z","timestamp":1660171092000},"page":"167-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Butyrolactone I attenuates inflammation in murine NASH by inhibiting the NF-\u03baB signaling pathway"],"prefix":"10.1016","volume":"626","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3833-0107","authenticated-orcid":false,"given":"Chen","family":"Tian-qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deng","family":"Yan-fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Yan-yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7222-2142","authenticated-orcid":false,"given":"Zhang","family":"Yong-hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2022.07.050_bib1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.phrs.2018.09.029","article-title":"Comment to 'Letter to the editor: human-based systems: mechanistic NASH modelling just around the corner?'[J]","volume":"137","author":"Boeckmans","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.bbrc.2022.07.050_bib2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cgh.2020.05.064","article-title":"Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States[J]","volume":"19","author":"Younossi","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.bbrc.2022.07.050_bib3","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","article-title":"NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances[J]","volume":"113","author":"Noureddin","year":"2018","journal-title":"Am. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.bbrc.2022.07.050_bib4","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China[J]","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bbrc.2022.07.050_bib5","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030[J]","volume":"69","author":"Estes","year":"2018","journal-title":"J.\u00a0Hepatol."},{"issue":"11","key":"10.1016\/j.bbrc.2022.07.050_bib6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrd.2016.188","article-title":"Nonalcoholic steatohepatitis (NASH) drugs market[J]","volume":"15","author":"Cassidy","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2022.07.050_bib7","article-title":"Therapies in non-alcoholic steatohepatitis (NASH)[J]","volume":"37","author":"Oseini","year":"2017","journal-title":"Liver Int."},{"issue":"7","key":"10.1016\/j.bbrc.2022.07.050_bib8","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies[J]","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.bbrc.2022.07.050_bib9","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1021\/acs.jnatprod.0c00344","article-title":"Antibacterial and NF-kappaB inhibitory lumazine peptides, aspochalasin, gamma-butyrolactone derivatives, and cyclic peptides from a Hawaiian Aspergillus flavipes[J]","volume":"83","author":"Wang","year":"2020","journal-title":"J.\u00a0Nat. Prod."},{"issue":"11","key":"10.1016\/j.bbrc.2022.07.050_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26113354","article-title":"Anti-inflammatory, antiallergic, and COVID-19 main protease (M(pro)) inhibitory activities of butenolides from a marine-derived fungus Aspergillus terreus[J]","volume":"26","author":"Uras","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2022.07.050_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104871","article-title":"Butyrolactone and sesquiterpene derivatives as inhibitors of iNOS from the roots of Lindera glauca[J]","volume":"111","author":"Ruan","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bbrc.2022.07.050_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202000956","article-title":"Chemical investigation of marine-derived fungus Aspergillus flavipes for potential anti-inflammatory agents[J]","volume":"18","author":"Tilvi","year":"2021","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bbrc.2022.07.050_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2021.104856","article-title":"Bioactive aromatic butenolides from a mangrove sediment originated fungal species, Aspergillus terreus SCAU011[J]","volume":"150","author":"Bao","year":"2021","journal-title":"Fitoterapia"},{"issue":"2","key":"10.1016\/j.bbrc.2022.07.050_bib14","first-page":"149","article-title":"Peptides and polyketides isolated from the marine sponge-derived fungus Aspergillus terreus SCSIO 41008[J]","volume":"17","author":"Luo","year":"2019","journal-title":"Chin. J. Nat. Med."},{"issue":"11","key":"10.1016\/j.bbrc.2022.07.050_bib15","doi-asserted-by":"crossref","first-page":"12616","DOI":"10.1096\/fj.201901061R","article-title":"Butyrolactone-I, an efficient \u03b1-glucosidase inhibitor, improves type 2 diabetes with potent TNF-\u03b1-lowering properties through modulating gut microbiota in db\/db mice[J]","volume":"33","author":"Wu","year":"2019","journal-title":"Faseb. J."},{"issue":"11","key":"10.1016\/j.bbrc.2022.07.050_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/md18110526","article-title":"Synthesis and biological evaluation of analogues of butyrolactone I as PTP1B inhibitors[J]","volume":"18","author":"Hong","year":"2020","journal-title":"Mar. Drugs"},{"issue":"9","key":"10.1016\/j.bbrc.2022.07.050_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26092816","article-title":"Production of terretonin N and butyrolactone I by thermophilic TM8 promoted apoptosis and cell death in human prostate and ovarian cancer cells[J]","volume":"26","author":"Ghfar","year":"2021","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bbrc.2022.07.050_bib18","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)[J]","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.bbrc.2022.07.050_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.748118","article-title":"Coral-Derived endophytic fungal product, butyrolactone-I, alleviates lps induced intestinal epithelial cell inflammatory response through TLR4\/NF-\u03baB and MAPK signaling pathways: an and studies[J]","volume":"8","author":"Chen","year":"2021","journal-title":"Front. Nutr."},{"issue":"6","key":"10.1016\/j.bbrc.2022.07.050_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/md16060202","article-title":"Butyrolactone-I from coral-derived fungus attenuates neuro-inflammatory response via suppression of NF-\u03baB pathway in BV-2 cells[J]","volume":"16","author":"Zhang","year":"2018","journal-title":"Mar. Drugs"},{"issue":"11","key":"10.1016\/j.bbrc.2022.07.050_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26113354","article-title":"Anti-inflammatory, antiallergic, and COVID-19 main protease (M) inhibitory activities of butenolides from a marine-derived fungus","volume":"26","author":"Uras","year":"2021","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bbrc.2022.07.050_bib22","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","article-title":"Pathogenesis of nonalcoholic steatohepatitis[J]","volume":"150","author":"Machado","year":"2016","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.bbrc.2022.07.050_bib23","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.21655","article-title":"Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis[J]","volume":"45","author":"Yamaguchi","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bbrc.2022.07.050_bib24","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but No other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease[J]","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bbrc.2022.07.050_bib25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.gastro.2007.05.012","article-title":"Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction[J]","volume":"133","author":"Richardson","year":"2007","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bbrc.2022.07.050_bib26","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites[J]","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bbrc.2022.07.050_bib27","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/liv.12531","article-title":"Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD[J]","volume":"35","author":"Vespasiani-Gentilucci","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.bbrc.2022.07.050_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-981-10-8684-7_3","article-title":"Pathogenesis of NASH: how metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease[J]","volume":"1061","author":"Farrell","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.bbrc.2022.07.050_bib29","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jcmgh.2021.12.002","article-title":"Sphingosine 1-phosphate receptor 4 promotes nonalcoholic steatohepatitis by activating NLRP3 inflammasome[J]","volume":"13","author":"Hong","year":"2022","journal-title":"Cell Mol. Gastroentrol. Hepatol."},{"issue":"6","key":"10.1016\/j.bbrc.2022.07.050_bib30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/13543776.2016.1185415","article-title":"Recent progress in the development of Toll-like receptor (TLR) antagonists[J]","volume":"26","author":"Patra","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"issue":"6","key":"10.1016\/j.bbrc.2022.07.050_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2004663","article-title":"Development of novel NEMO-binding domain mimetics for inhibiting IKK\/NF-\u03baB activation[J]","volume":"16","author":"Zhao","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbrc.2022.07.050_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114657","article-title":"Daphnes Cortex and its licorice-processed products suppress inflammation via the TLR4\/NF-\u03baB\/NLRP3 signaling pathway and regulation of the metabolic profile in the treatment of rheumatoid arthritis[J]","volume":"283","author":"Meng","year":"2022","journal-title":"J.\u00a0Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.bbrc.2022.07.050_bib33","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2008.01.045","article-title":"Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice[J]","volume":"584","author":"Zheng","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2022.07.050_bib34","article-title":"A\u00a0combination of leucine, metformin, and sildenafil treats nonalcoholic fatty liver disease and steatohepatitis in mice[J]","volume":"2016","author":"Bruckbauer","year":"2016","journal-title":"Bangladesh Liver J."},{"issue":"6","key":"10.1016\/j.bbrc.2022.07.050_bib35","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/hep.23535","article-title":"Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease[J]","volume":"51","author":"Abdelmalek","year":"2010","journal-title":"Hepatology"},{"issue":"7800","key":"10.1016\/j.bbrc.2022.07.050_bib36","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-020-2101-7","article-title":"Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate[J]","volume":"579","author":"Zhao","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2022.07.050_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106822","article-title":"The adaptor protein c-Cbl-associated protein (CAP) limits pro-inflammatory cytokine expression by inhibiting the NF-\u03baB pathway[J]","volume":"87","author":"Vdovenko","year":"2020","journal-title":"Int. Immunopharm."},{"issue":"6","key":"10.1016\/j.bbrc.2022.07.050_bib38","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/med.21842","article-title":"The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases[J]","volume":"41","author":"Efferth","year":"2021","journal-title":"Med. Res. Rev."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22010191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22010191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:43:03Z","timestamp":1762094583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X22010191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":38,"alternative-id":["S0006291X22010191"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.07.050","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Butyrolactone I attenuates inflammation in murine NASH by inhibiting the NF-\u03baB signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.07.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}